Post-pregnancy pigmentation spots: why they resist where others fade

  • Share :

A brownish mask that settles over the cheekbones, the forehead and the upper lip during pregnancy, and then stays. Many women expect to see it leave along with the hormones, in the months following delivery. For others, it holds on. Melasma is in fact described as a chronic and recurring condition, with no curative treatment to date, whose manifestations we seek to control14. That is what explains why these spots are sometimes worked on years after the birth.

Why don’t these spots behave like sun spots?

Because they aren’t located in the same place. A classic sun spot, a lentigo, is pigment concentrated in the superficial layers of the skin. Melasma, for its part, comes with an increased quantity of melanin both in the epidermis and in the dermis, the deeper layer8. And the issue isn’t limited to melanocytes, those cells that manufacture pigment: skin affected by melasma shows alterations of the epidermis, of the basement membrane that separates it from the dermis, and of the superficial dermis, the whole sustaining the overproduction of pigment12.

That is the mechanical reason why these spots resist. You can remove pigment at the surface; the machinery that produces it remains underneath, ready to start up again.

Three families of triggers combine in people who are genetically predisposed: solar radiation, hormonal factors including pregnancy, and skin inflammation12. The trio explains why pregnancy so often lights the fuse, and why the skin stays reactive long afterward.

Chemical peel or gentle laser for post-pregnancy spots?

The question comes up constantly, and the honest answer is that it’s being asked backwards. Peels, lasers and microneedling are among the recognized strategies for controlling and preventing melasma14, and a review of melasma therapies puts forward the multimodal approach, which combines several levers, as the most effective13. Pigmentation treatments also require time before showing a visible effect15.

In practical terms, at Dermagyms, we begin by analyzing the skin with the Observ 520x in order to observe what is happening beneath the surface and isn’t visible to the naked eye. We look in particular at the pigmentary and inflammatory field, but also at the possible presence of a vascular component, which can contribute to sustaining melasma. This analysis makes it possible to adjust the protocol rather than applying the same treatment to every kind of pigmentation.

Our approach is generally multimodal and often rests on a combination of the Clarity II and the Hollywood Spectra, used according to different modalities and different parameters within a precise protocol developed by the medical direction. In-clinic treatments are also combined with an at-home protocol that may include, among other things, tranexamic acid, hydroquinone when it is indicated, as well as specialized sun protection. The number of sessions, the technologies used and the maintenance rhythm vary from person to person and according to what the skin analysis reveals.

A useful clarification: at Dermagyms, we do not use chemical peels to treat melasma, in order to avoid provoking inflammation that could sustain the pigmentation. IPL phototherapy, for intense pulsed light, is not the option retained for this type of pigmentation either. What sets melasma apart from other spots also changes what we apply to it.

How do I know whether my spots warrant an esthetic treatment?

By looking at what they are, before choosing anything at all. An isolated sun spot on the cheekbone, marks left by acne and post-pregnancy melasma don’t call for the same parameters, even if they look alike in the mirror. That’s what an analysis session with the Observ 520x is for: different lighting modes, including ultraviolet, reveal how the pigment is distributed beneath the surface, and the team interprets what it sees. A skin condition that falls outside the esthetic field is referred to the team’s physician.

Do spots fade better in clinic than at home?

A consumer light device used on its own in front of the mirror allows neither for dosing the energy according to phototype, nor for knowing at what depth the pigment sits. Yet on a pigmentation that lives partly beneath the surface, those two settings are what guides everything else, and they call for a trained eye and a professional device.

That said, one at-home step counts, and it’s the most ordinary one: sun protection. In a consensus conducted among 601 specialists and then an expert panel, broad-spectrum photoprotection emerged as the best-rated measure across the full set of clinical scenarios examined, melasma included, with an advantage for tinted formulas that also filter visible light2. The same tinted and mineral formulas are recommended during pregnancy, a period when the skin responds differently to UV rays and when sunscreen use generally remains low4. That panel also set aside certain common anti-aging actives during the postpartum period and breastfeeding2.

What to remember about pregnancy melasma

These spots resist because they aren’t merely a deposit of colour at the surface: this is skin whose deeper organization sustains the production of pigment12. They therefore don’t fade the way a sun spot does, and they aren’t treated with the same tools. What works looks more like control over time than erasure: identifying where the pigment sits, choosing treatments for which melasma is genuinely among the indications, and keeping up photoprotection all year long, including during the months when the Montreal sun keeps a low profile.

—

✍️ Article written by Edouard

Owner of Dermagyms, a medical aesthetic clinic in Montreal.

At Dermagyms, every treatment is personalized based on the skin analysis, the skin type and the client’s goals, under medical supervision.

⭐ 4.9★ on Google | 10+ years of experience

Book your free consultation, including an advanced skin analysis with the Observ 520x.

Sources

  1. Zhao X, Wang J, Song J, He Y, Zhang X, Ma Q, Gu Y, Lin L (2026) Prenatal Fetal Neurocutaneous Melanosis: A Case Report and Literature Review — Molecular genetics & genomic medicine
  2. Rageh MA, Seoudy WM, Abozeid MF, Elkholy AM, Moubasher AEA, Abdel-Latif AM, Attallah DAA, Mohamed EM, Assaf HA, Sabry H, Nasr MM, Hegazy MS, Hunter N, Zuelfakkar N, Bedair NI, Mohammed NE, Abdelkodous SF, Gohary YM, Mohy SM (2026) Egyptian National Consensus on Dermocosmetic Ingredient Selection Across Common Dermatology Scenarios: A RAND/UCLA Appropriateness Study — Dermatology and therapy
  3. GASPER SINGFRID MUNG’ONG’O, Daniel Msilanga, Paul Alikado Sabuni, Humphrey G Medarakini, Gladys Reuben Mahiti, Rose Mpembeni (2026) Adherence to National Standard Treatment Guidelines in the management of hypertension and associated factors among healthcare providers at public district hospitals in Dar es Salaam, Tanzania — PLOS Global Public Health
  4. Lim HW, Piquero-Casals J, Schalka S, Leone G, Trullàs C, Brown A, Foyaca M, Gilaberte Y, Krutmann J, Passeron T (2025) Photoprotection in pregnancy: addressing safety concerns and optimizing skin health — Frontiers in medicine
  5. Ramona Marrapodi, Alberto Marini, Barbara Bellei (2025) Dysregulated Intracellular Signaling in the Pathogenesis of Vitiligo: An Update on Emerging Therapeutic Strategies — Biomedicines
  6. (2024) Abstracts — Lasers in Surgery and Medicine
  7. Amin Mahmood Thawabteh, Alaa Jibreen, Donia Karaman, Alà Thawabteh, Rafik Karaman (2023) Skin Pigmentation Types, Causes and Treatment—A Review — Molecules
  8. Wei Liu, Qin Chen, Yumin Xia (2023) New Mechanistic Insights of Melasma — Clinical Cosmetic and Investigational Dermatology
  9. Makino ET, Jiang LI, Stephens TJ, Mikati M, Mehta RC (2022) Pigmentation control in pregnancy-induced melasma: Clinical assessment of a non-hydroquinone, non-retinol pigment-correcting serum — Journal of cosmetic dermatology
  10. Ibrahim SA, Kang BY, Schlessinger DI, Chiren SG, Tang JC, Kirkham JJ, Schmitt J, Poon E, Maher IA, Sobanko JF, Cartee TV, Alam M (2022) Protocol for development of a core outcome set for clinical trials in melasma — BMJ open
  11. Akarsu M, Onem S, Htway Z, Cengiz O, Dolu S, Iyilikci L (2022) Double Balloon Enteroscopy in a Pregnant Woman with Peutz-Jeghers Syndrome — Journal of the College of Physicians and Surgeons–Pakistan : JCPSP
  12. Ana Cláudia Cavalcante Espósito, Daniel Pinho Cassiano, Carolina Nunhez da Silva, Paula Basso Lima, Joana Alexandria Ferreira Dias, Karime Marques Hassun, Ediléia Bagatin, Luciane Donida Bartoli Miot, Hélio Amante Miot (2022) Update on Melasma—Part I: Pathogenesis — Dermatology and Therapy
  13. Vikram K. Mahajan, Anant Patil, Leszek Blicharz, Martin Kassir, Nellie Konnikov, Michael H. Gold, Mitchel P. Goldman, Hassan Galadari, Mohamad Goldust (2022) Medical therapies for melasma — Journal of Cosmetic Dermatology
  14. Daniel Pinho Cassiano, Ana Cláudia Cavalcante Espósito, Carolina Nunhez da Silva, Paula Basso Lima, Joana Alexandria Ferreira Dias, Karime Marques Hassun, Luciane Donida Bartoli Miot, Hélio Amante Miot, Ediléia Bagatin (2022) Update on Melasma—Part II: Treatment — Dermatology and Therapy
  15. Avni Nautiyal, Sarika Wairkar (2021) Management of hyperpigmentation: Current treatments and emerging therapies — Pigment Cell & Melanoma Research
  16. Mohammad Ahmad Abdalla (2021) Melasma Clinical Features, Diagnosis, Epidemiology and Etiology: An Update Review — Siriraj Medical Journal/San Sirirat
  17. Silke Schrom, Thomas Hebesberger, Stefanie Angela Wallner, Ines Anders, Erika Richtig, Waltraud Brandl, Birgit Hirschmugl, Mariangela Garofalo, Claudia Bernecker, Peter Schlenke, Karl Kashofer, Christian Wadsack, Ariane Aigelsreiter, Ellen Heitzer, Sabrina Riedl, Dagmar Zweytick, Nadine Kretschmer, Georg Richtig, Beate Rinner (2021) MUG Mel3 Cell Lines Reflect Heterogeneity in Melanoma and Represent a Robust Model for Melanoma in Pregnancy — International Journal of Molecular Sciences

Other articles you might like:

Question?

Contact us

Have a question? Book your free consultation or call us directly!